Cibc World Markets Corp Edwards Lifesciences Corp Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 81,772 shares of EW stock, worth $6.12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

81,772

Previous 77,552 5.44%

Holding current value

$6.12 Million

Previous $7.16 Million 24.67%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $251,934 - $395,751	4,220 Added 5.44%	81,772 $5.4 Million
Q2 2024 Aug 12, 2024	BUY	$84.3 - $94.31 $1.41 Million - $1.58 Million	16,736 Added 27.52%	77,552 $7.16 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $1.25 Million - $1.65 Million	-17,294 Reduced 22.14%	60,816 $5.81 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $2.75 Million - $3.46 Million	44,557 Added 132.8%	78,110 $5.96 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $2.6 Million - $3.5 Million	-37,501 Reduced 52.78%	33,553 $2.32 Million
Q2 2023 Aug 04, 2023	BUY	$81.41 - $94.33 $3.24 Million - $3.75 Million	39,789 Added 127.26%	71,054 $6.7 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $3.08 Million - $3.5 Million	-41,421 Reduced 56.99%	31,265 $2.59 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $4.32 Million - $5.53 Million	63,279 Added 672.68%	72,686 $5.42 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $2.8 Million - $3.65 Million	-33,997 Reduced 78.33%	9,407 $777,000
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $7.36 Million - $10.9 Million	-85,037 Reduced 66.21%	43,404 $4.13 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $1.09 Million - $1.37 Million	10,696 Added 9.08%	128,441 $15.1 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $2.44 Million - $2.99 Million	-22,904 Reduced 16.28%	117,745 $15.3 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $10 Million - $12 Million	97,487 Added 225.86%	140,649 $15.9 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $1.37 Million - $1.72 Million	-16,381 Reduced 27.51%	43,162 $4.47 Million
Q1 2021 May 07, 2021	SELL	$78.68 - $90.67 $21.8 Million - $25.1 Million	-276,529 Reduced 82.28%	59,543 $4.98 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $14.3 Million - $18.2 Million	199,459 Added 146.0%	336,072 $30.7 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $5.09 Million - $6.62 Million	75,762 Added 124.5%	136,613 $10.9 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $2.62 Million - $3.51 Million	45,586 Added 298.63%	60,851 $4.21 Million
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $1.33 Million - $2.06 Million	-25,394 Reduced 62.46%	15,265 $2.88 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $2.45 Million - $2.8 Million	-34,136 Reduced 45.64%	40,659 $9.49 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $1.67 Million - $2.05 Million	27,153 Added 56.99%	74,795 $16.4 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $116,552 - $134,681	-2,091 Reduced 4.2%	47,642 $8.8 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $865,228 - $1.16 Million	-18,067 Reduced 26.65%	49,733 $9.52 Million
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $459,551 - $563,819	9,902 Added 17.1%	67,800 $10.4 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $505,167 - $641,463	11,054 Added 23.6%	57,898 $10.1 Million
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $335,737 - $405,731	7,909 Added 20.31%	46,844 $6.82 Million
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $304,920 - $389,042	-8,199 Reduced 17.4%	38,935 $5.43 Million
Q4 2017 Feb 13, 2018	BUY	$33.79 - $39.39 $495,969 - $578,166	14,678 Added 45.22%	47,134 $5.31 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $1.18 Million - $1.26 Million	32,456	32,456 $3.55 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Edwards Lifesciences Corp Transaction History